Table 4.
Salt (*) or Co-crystal | M.P.of Co-crystallizing Agent | M.P.of Salt(*)or Co-crystal | M.P.of Diclofenac |
---|---|---|---|
(DC)·(3-aminopyridine)* | 55–58 °C | 108–112°C* | 171–173 °C |
(DC)·(2-aminopyridine)* | 47–50 °C | 73–74 °C* | 171–173 °C |
(DC)·(AMP) | 151–153 °C | 173–174 °C | 171–173 °C |
(DC)·(ACMP) | 182–183 °C | 169–172 °C | 171–173 °C |
(DC)·(3-hydroxypyridine) | 126–129 °C | 153–156 °C | 171–173 °C |
(DC)·(2-amino-4-hydroxy-6-methylpyrimidine) | >300 °C | >160 °C [sublimes] | 171–173 °C |
(DC)·(AP) | 125–127 °C | 168–172 °C | 171–173 °C |
(DC)·(4,4′-bipyridyl) | 108–111 °C | 155–157 °C | 171–173 °C |
(DC)·(2-amino-5-chloropyridine) | 132–135 °C | 150–154 °C | 171–173 °C |
(DC)·(4-chloro-2,6-diaminopyrimidine) | 196–199 °C | 155–160 °C | 171–173 °C |
(DC)·(2-amino-3,5-dibromopyridine) | 98–100 °C | 145–150 °C | 171–173 °C |